This week's top news stories and latest developments

📈 Trending news from the industry

'Novel protein function inhibitor regenerated myelin sheaths'

Researchers showed that ESI1, or similar compounds, may help to slow or even reverse cognitive losses that can occur during aging.

>> READ MORE <<

'Biomarker identification in the realm of rare diseases'

In this Q&A, Debiopharm’s Principal Scientist Dr Luke Piggott defines the critical requirement of biomarkers for identifying rare diseases. He illuminates how AI-enhanced approaches are accelerating the drug discovery process, particularly regarding clinical trial enrolment, and the breakthroughs he hopes to see in the future.

>> READ MORE <<

'Associations of AML MRD levels with posttransplant clinical outcomes'

Patients with no detectable FLT3 mutations had the best outcomes after an allogenic hematopoietic cell transplant.

>> READ MORE <<

'Nanoparticle targets primary tumours and brain metastases'

A specialised drug-loaded nanoparticle, which can cross the blood-brain barrier, shrunk both breast tumours and breast cancer cells.

>> READ MORE <<

'Women in Stem with Stefanie Flückiger-Mangual'

Stefanie Flückiger-Mangual , Chief Executive Officer, is one of TOLREMO’s scientific founders and an expert in drug resistance in cancer therapy. She is a biomedical scientist and biochemist by training (University of Fribourg and ETH Zurich, Switzerland) and holds a PhD in Molecular and Translational Biomedicine from ETH Zurich. She led the team of scientists who discovered novel molecular mechanisms that can be exploited to prevent the development of non-genetic resistance to cancer therapies.

>> READ MORE <<

💻 What to watch

Join Dr Carleton Sage to learn about predicting ADME properties as a key approach to improving the efficiency of small molecule drug discovery. AI ADME model development approaches and case studies within drug discovery projects will be discussed.

📅 Date: 26 June

⏰ Time: 16:00 BST

>> REGISTER TODAY <<

📘 What to read

Interested in the latest cell and gene developments? This report provides a comprehensive overview of advancements in cell and gene therapy, highlighting the potential of innovative approaches in drug discovery.

>> READ NOW <<

Sign up for free! 🖊️

Sign up here to stay ahead of all the latest breaking news, expert insights and the newest trends in global drug discovery.

Drug Target Review is an essential multimedia resource which is trusted and recognised globally of researchers and scientific leaders who cover the most up-to-date innovations, and cutting edge technologies in the industry.